Cecilie Velsø Mæng

Cecilie Velsø Mæng serves as a Guest Researcher in the Grønbæk Group at the Biotech Research and Innovation Centre (BRIC), University of Copenhagen, under the Faculty of Health and Medical Sciences. Her work focuses on clinical hematology with direct implications for diagnostic protocols in plasma cell disorders.

Her research specializes in biomarker optimization for monoclonal gammopathy of undetermined significance (MGUS), particularly examining free light chain reference intervals to improve risk assessment models and prevent clinical overdiagnosis. This translational work bridges laboratory medicine and patient care through evidence-based diagnostic refinement.

Current research trends indicate strong emphasis on diagnostic precision in pre-malignant hematological conditions, with her 2025 publication establishing revised clinical thresholds that enhance stratification accuracy while reducing unnecessary interventions. Collaborative patterns show international engagement with Danish and Icelandic institutions.

She operates within BRIC's research infrastructure at Ole Maaløes Vej 5, Copenhagen, contributing to the Grønbæk Group's mission in cancer biology and therapeutic development through specialized laboratory investigations.